This is a preview of subscription content, log in via an institution to check access.
Notes
The study was funded by Sanofi Pasteur.
Reference
Redondo E, et al. Cost-utility analysis of influenza vaccination in a population aged 65 years or older in Spain with a high-dose vaccine versus an adjuvanted vaccine. Vaccine : 31 Jul 2021. Available from: URL: http://doi.org/10.1016/j.vaccine.2021.07.048
Rights and permissions
About this article
Cite this article
Switch to high-dose quadrivalent influenza vaccine cost effective for elderly in Spain. PharmacoEcon Outcomes News 885, 23 (2021). https://doi.org/10.1007/s40274-021-07965-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-07965-9